The purpose of this survey is to gather global information from members and non-members of SPS involved in CNS testing in drug development. This survey will be the first CNS specific assessment of industry practices and will benefit all areas of safety testing that involve neurological system evaluations.
The survey will identify industry trends in drug development and current practices with nonclinical CNS safety testing.
We anticipate that it will take about 10-15 minutes to complete the survey. To show our appreciation for your time, you will be included in a prize drawing for an iPad! (2 prizes available) Sponsored by Covance and CiToxLAB.
Participate in the CNS Testing in Drug Development Survey
Be assured that your name will not be associated with the data; the SPS office will ensure that all data are analyzed and presented without correlation to participant names. All responses will be kept anonymous and the data gathered will only be used in the aggregate.
The data from this survey will be used to prepare SPS presentations and publications and the results of the survey will be shared with all SPS members and participating societies. The deadline to complete the survey is May 30th.